혈액제제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global blood preparation market size is expected to reach USD 99.88 Billion in 2034 from USD 58.62 Billion in 2025, growing at a CAGR of 6.1 during 2026-2034.This market is growing steadily due to increasing demand for blood components in surgeries, trauma care, cancer treatment, and chronic disease management. Rising prevalence of hematological disorders and growing awareness regarding blood donation programs are supporting market expansion. Healthcare institutions are investing in advanced blood processing technologies to improve storage, separation, and transfusion efficiency. Increasing adoption of automated blood preparation systems is also enhancing laboratory productivity and minimizing contamination risks.

Technological advancements in centrifugation systems, blood analyzers, and pathogen reduction technologies are significantly improving blood preparation procedures. Hospitals and blood banks are focusing on safer transfusion practices and efficient inventory management to meet rising healthcare demands. Government initiatives promoting voluntary blood donation and strengthening healthcare infrastructure are further contributing to market development. The growing geriatric population and increasing surgical procedures worldwide are creating sustained demand for blood preparation products and services.

Future growth opportunities are expected to emerge from automation, digital tracking systems, and advanced plasma separation technologies. Developing economies are witnessing rising investments in healthcare infrastructure, which is likely to support broader adoption of blood preparation equipment. Research activities focusing on artificial blood substitutes and improved storage techniques may reshape the industry landscape over time. Strategic collaborations among healthcare providers and technology companies are anticipated to drive innovation and strengthen long-term market growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Whole Blood
• Blood Components
• Blood Derivatives

By Blood Thinning Agents

• Anticoagulants
• Fibrinolytics
• Platelet Aggregation Inhibitors

By Application

• Thrombocytosis
• Pulmonary Embolism
• Renal Impairment
• Other Applications

By End User

• Hospitals & Surgical Centers
• Blood & Plasma Banks
• Other End Users

COMPANIES PROFILED

• CSL Behring, Takeda Pharmaceutical Company Limited, Baxter International Inc., Grifols S.A., Octapharma AG, Pfizer Inc., Bayer AG, Sanofi, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, GlaxoSmithKline plc, LEO Pharma A/S, Abbott Laboratories, Haemonetics Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD PREPARATION MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Whole Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Blood Components Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Blood Derivatives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD PREPARATION MARKET: BY BLOOD THINNING AGENTS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Blood Thinning Agents
• 5.2. Anticoagulants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Fibrinolytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Platelet Aggregation Inhibitors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD PREPARATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Thrombocytosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pulmonary Embolism Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Renal Impairment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOOD PREPARATION MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals & Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Blood & Plasma Banks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BLOOD PREPARATION MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Blood Thinning Agents
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Blood Thinning Agents
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Blood Thinning Agents
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Blood Thinning Agents
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Blood Thinning Agents
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BLOOD PREPARATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 CSL Behring
  • 10.2.2 Takeda Pharmaceutical Company Limited
  • 10.2.3 Baxter International Inc
  • 10.2.4 Grifols S.A
  • 10.2.5 Octapharma AG
  • 10.2.6 Pfizer Inc
  • 10.2.7 Bayer AG
  • 10.2.8 Sanofi
  • 10.2.9 Bristol-Myers Squibb Company
  • 10.2.10 Boehringer Ingelheim International GmbH
  • 10.2.11 Daiichi Sankyo Company Limited
  • 10.2.12 GlaxoSmithKline Plc
  • 10.2.13 LEO Pharma A/S
  • 10.2.14 Abbott Laboratories
  • 10.2.15 Haemonetics Corporation